Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Furazidin
2. Solafur
1. Furazidin
2. 1672-88-4
3. Furazidine
4. Akritoin
5. Furaginum
6. 1-((3-(5-nitro-2-furyl)allylidene)amino)hydantoin
7. 1-[(e)-[(e)-3-(5-nitrofuran-2-yl)prop-2-enylidene]amino]imidazolidine-2,4-dione
8. K2r4n34y9i
9. Nf 416
10. F-35
11. 1-((3-(5-nitro-2-furyl)allylidene)amino)-hydantoin
12. 1-[(e)-[(z)-3-(5-nitrofuran-2-yl)prop-2-enylidene]amino]imidazolidine-2,4-dione
13. Furamag
14. 1-((3-(5-nitrofuran-2-yl)allylidene)-amino)imidazolidine-2,4-dione
15. 1-(((1e,2e)-3-(5-nitrofuran-2-yl)allylidene)amino)imidazolidine-2,4-dione
16. 1-{[(1e,2e)-3-(5-nitrofuran-2-yl)prop-2-en-1-ylidene]amino}imidazolidine-2,4-dione
17. Ccris 1199
18. 1-(3-(5-nitro-2-furyl)-n-2-propenylidine)amino-hydantoin
19. Brn 0307076
20. Unii-k2r4n34y9i
21. Furagin (tn)
22. Furazidin [mart.]
23. Furazidin [who-dd]
24. 1-[3-(5-nitro-2-furyl)allylidenamino]hydantoin
25. 4-24-00-01048 (beilstein Handbook Reference)
26. Schembl3194895
27. Chembl3707254
28. Hydantoin, 1-((3-(5-nitro-2-furyl)allylidene)amino)-
29. Schembl17292896
30. J01xe03
31. Dtxsid101030908
32. Ex-a1974
33. Bdbm50549808
34. S3709
35. Stk368597
36. Zinc31430194
37. 1-((3-(5-nitro-2-furanyl)-2-propenylidene)amino)-4-imidazolidinedione
38. 2,4-imidazolidinedione, 1-((3-(5-nitro-2-furanyl)-2-propenylidene)amino)-
39. Akos005444359
40. Ccg-267084
41. Cs-0798
42. Db13475
43. Bs-49182
44. Hy-77036
45. D07998
46. 672f884
47. A810846
48. 1-(3-(5-nitro-2-furyl)-n-2-propenylidine)aminohydantoin
49. 1-(((e)-3-(5-nitrofuran-2-yl)prop-2-enylidene)amino)imidazolidine-2,4-dione
50. 2,4-imidazolidinedione, 1-[[3-(5-nitro-2-furanyl)-2-propen-1-ylidene]amino]-
Molecular Weight | 264.19 g/mol |
---|---|
Molecular Formula | C10H8N4O5 |
XLogP3 | 0.5 |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 6 |
Rotatable Bond Count | 3 |
Exact Mass | 264.04946937 g/mol |
Monoisotopic Mass | 264.04946937 g/mol |
Topological Polar Surface Area | 121 Ų |
Heavy Atom Count | 19 |
Formal Charge | 0 |
Complexity | 455 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 2 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Anti-Infective Agents, Urinary
Substances capable of killing agents causing urinary tract infections or of preventing them from spreading. (See all compounds classified as Anti-Infective Agents, Urinary.)
J - Antiinfectives for systemic use
J01 - Antibacterials for systemic use
J01X - Other antibacterials
J01XE - Nitrofuran derivatives
J01XE03 - Furazidin
Olpha, a JSC AB City subsidiary, is a leading Baltic firm with 50 years of experience in medicines & chemical pharmaceuticals.
Details:
In partnership Olainfarm will manage Furagins (Furaginum) regulatory affairs, distribution and promotion in Latvia, Russia, Kazakhstan, Belarus, Ukraine, and other countries and Adalvo will be responsible for development, manufacturing and will support market activities.
Lead Product(s): Furazidin
Therapeutic Area: Infections and Infectious Diseases Brand Name: Furagins
Study Phase: ApprovedProduct Type: Small molecule
Sponsor: Not Applicable
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Agreement June 16, 2021
Lead Product(s) : Furazidin
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Approved
Partner/Sponsor/Collaborator : Not Applicable
Deal Size : Undisclosed
Deal Type : Agreement
JSC Olainfarm & Adalvo to Launch a New Urology Product in 17 Countries In 2022-2023
Details : In partnership Olainfarm will manage Furagins (Furaginum) regulatory affairs, distribution and promotion in Latvia, Russia, Kazakhstan, Belarus, Ukraine, and other countries and Adalvo will be responsible for development, manufacturing and will support m...
Brand Name : Furagins
Molecule Type : Small molecule
Upfront Cash : Undisclosed
June 16, 2021
Olpha, a JSC AB City subsidiary, is a leading Baltic firm with 50 years of experience in medicines & chemical pharmaceuticals.
Regulatory Info :
Registration Country : Latvia
Brand Name : Furasol
Dosage Form : Powder for Preparation...
Dosage Strength : 100MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Latvia
Olpha, a JSC AB City subsidiary, is a leading Baltic firm with 50 years of experience in medicines & chemical pharmaceuticals.
Packaging :
Regulatory Info :
Dosage : Powder for Preparation...
Dosage Strength : 100MG
Brand Name : Furasol
Approval Date :
Application Number :
Registration Country : Latvia
Olpha, a JSC AB City subsidiary, is a leading Baltic firm with 50 years of experience in medicines & chemical pharmaceuticals.
Regulatory Info :
Registration Country : Latvia
Brand Name : Furagin
Dosage Form : Tablet
Dosage Strength : 50MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Latvia
Olpha, a JSC AB City subsidiary, is a leading Baltic firm with 50 years of experience in medicines & chemical pharmaceuticals.
Packaging :
Regulatory Info :
Dosage : Tablet
Dosage Strength : 50MG
Brand Name : Furagin
Approval Date :
Application Number :
Registration Country : Latvia
Regulatory Info :
Registration Country : Poland
Brand Name : Furaginum Hasco
Dosage Form : Tablets
Dosage Strength : 50MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Poland
Packaging :
Regulatory Info :
Dosage : Tablets
Dosage Strength : 50MG
Brand Name : Furaginum Hasco
Approval Date :
Application Number :
Registration Country : Poland
Market Place
Reply
04 Sep 2024
Reply
22 Mar 2022
ANALYTICAL
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?